Repligen posted solid growth and beat Wall Street's sales and adjusted earnings estimates.

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Moving forward, Shift4 Payments has raised its guidance for key financial metrics, including its gross revenue less network ...

Short-term federal tax matches ordinary rates; long-term capped at 15-20% for most brackets. Missouri taxes all capital gains ...

Equity analysts in Manhattan have a difficult time imagining the logistics needs in Brazil. In this podcast, Motley Fool ...

The meat industry powerhouse reported a strong bottom-line recovery, with profitability rebounding in key segments.

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial ...

Cronos Group ( CRON 12.13%) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 ...

Lucid reported third-quarter financial results last week and had a net loss of $992 million. The company is trying to ...

Home Depot reported decent revenue growth for Q3 thanks, in part, to hurricane activity, but it experienced a decline in net ...

The company posted an earnings per share loss of $0.25. Development progress reported for key drugs, including brepocitinib ...

The IT services specialist delivered stable revenue growth in its fiscal 2025 first quarter, but profits sank.